Science News for International Stroke Conference 2021
A Fully Virtual Experience
#ISC21 Science News coverage brings you results and insights into this year's Tier 1 late-breaking cardiovascular science trials presented at International Stroke Conference 2021. Find at-a-glance data summaries, exclusive interviews, simultaneous publications, and more – all in one place.
Jump to one day's coverage: Wednesday | Thursday | Friday
Quick Reference:
In Stroke: International Stroke Conference 2021 Abstracts | #ISC21 Digital Newspaper | AHA News (Consumer) Stories
AHA Journals Simultaneous Publications
Wednesday's Selected Science
ANGIO-CAT
Evaluation Of Direct Transfer To Angiography Suite Vs. Computed Tomography Suite In Endovascular Treatment Of Stroke: ANGIO-CAT Randomized Clinical Trial
Manuel Requena | Vall d'Hebron Hospital, Barcelona, Spain
- RESULTS: ANGIO-CAT showed direct transfer of patients with suspected large vessel occlusion to the angiography suite saved time and improved outcomes at three months.
- ANGIO-CAT Abstract (link opens in new window)(link opens in new window)
- ClinicalTrials: NCT04001738 (link opens in new window)
- ANGIO-CAT Trial data summary slide (PDF)
ANGIO-CAT Results
BEST-MSU
Benefits Of Stroke Treatment Delivered By A Mobile Stroke Unit Compared To Standard Management By Emergency Medical Services (BEST-MSU Study)
James Grotta | Memorial Hermann Hospital TMC, Houston, TX
- RESULTS: BEST-MSU found that stroke patients managed and treated by mobile stroke unit showed more patients were treated and in a shorter time, with improved outcomes.
- BEST-MSU Abstract (link opens in new window)(link opens in new window)
- ClinicalTrials: NCT02190500 (link opens in new window)
- BEST-MSU Study data summary slide (PDF)
BEST-MSU Results
Presidential Address
Working Towards Achieving Cerebrovascular Health Equity
Mitch Elkind, MD, MS, FAHA, president of the American Heart, American Stroke Association, Louise McCullough, MD, PhD, chair of the International Stroke Conference (ISC) 2021, Bruce Ovbiagele, MD, MSc, MAS, MBA, past chair of ISC, and Olajide Williams, MD review some of the challenges and opportunities discussed in the session, "Racing to Greater Life Expectancy by 2030: Is Racism a Tangible Target to Achieve Cerebrovascular Health Equity."
#ISC21 Daily Recap Day One
ICYMI: Updates to 2009 Comprehensive Nursing Care Scientific Statement on Acute Ischemic Stroke
Last week, the AHA released an update to the 2009 Comprehensive Overview of Nursing and Interdisciplinary Care of the Acute Ischemic Stroke patient, a seminal paper for nursing care of stroke patients.
- Links to 3 papers in Stroke
- Prehospital and Acute Phase of Care
- Endovascular/ICU-Postinterventional Therapy
- Posthyperacute and Prehospital Discharge
- Top Things To Know
- Three Commentaries
- Recommended Reading and Related Resources
Thursday's Selected Science
MR CLEAN-NO IV
Intravenous Thrombolysis Followed By Endovascular Thrombectomy Versus Direct Endovascular Thrombectomy: A Randomized Controlled Trial
Yvo Roos | Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
- RESULTS: MR CLEAN-NO IV showed no non-inferiority or superiority of dEVT over alteplase + EVT in patients with ischemic stroke due to proximal anterior circulation occlusions.
- MR CLEAN-NO IV Abstract (link opens in new window)(link opens in new window)
- ISRCTN: ISRCTN80619088 (link opens in new window)
- MR CLEAN NO IV Trial Home; (link opens in new window)
- MR CLEAN-NO IV Trial data summary slide (PDF)
MR CLEAN-NO IV Results
SHRINE
Systemic THrombolysis Randomization IN Endovascular Stroke Therapy (SHRINE) Collaboration
Raul Nogueira | Emory University, Atlanta, GA
- RESULTS: SHRINE collaboration offers more data on non-inferiority of primary EVT over combined IVT+EVT in patients with large vessel occlusion strokes
- SHRINE Abstract (link opens in new window)(link opens in new window)
- SKIP Trial
- SHRINE data summary slide (PDF)
SHRINE Results
#ISC21 Daily Recap Day Two
Friday's Selected Science
AURORA
Thrombectomy For Anterior Circulation Stroke Beyond 6 Hours From Time Last Known Well: Final Results Of the Aurora (analysis Of Pooled Data From Randomized Studies Of Thrombectomy More Than 6 Hours After Last Known Well ) Collaboration
Tudor G. Jovin | Cooper Neurological Institute, Camden, NJ
- RESULTS: AURORA: Findings from this study strengthen the evidence for benefit of endovascular thrombectomy across the 6-24-hour time window.
- AURORA Abstract (link opens in new window)(link opens in new window)
- AURORA data summary slide (PDF)
AURORA Results
EVT Trends from Get With The Guidelines-Stroke
National Temporal Trends In Endovascular Therapy (EVT) Utilization And Outcomes According To Race And Ethnicity: Findings From Get With The Guidelines (GWTG)-Stroke
Faheem Sheriff | Texas Tech University Health Science Center
- RESULTS: The GWTG Stroke registry provides data about EVT utilization and outcomes according to race and ethnicity
- EVT Trends from GWTG-Stroke Abstract (link opens in new window)(link opens in new window)
- EVT Trends from GWTG-Stroke data summary slide (PDF)